MetaCap

enGene Therapeutics Statistics

NASDAQ: ENGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.74-0.02 (-1.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

enGene Therapeutics by the numbers

enGene Therapeutics has a market capitalization of $116.6 million based on 67.02M shares outstanding. With trailing EPS of $-2.07, enGene Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.6% below its 50-day average and 53.6% below its 200-day average.

Average daily trading volume is 1.12M shares, or about $1.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ENGN valuation vs. peer median

ENGN compared with the median of 8 peer companies
MetricENGNPeer medianDifference
Market cap$116.61M$112.26M+4%
Avg. volume1.12M1.37M-18%

Peer median across 8 companies: IVVD, ARMP, HUMA, CMPX, FATE, CRDL, MOLN, IPHA.

Valuation

Price and trading

Previous close
1.76
Open
1.75
Day range
1.69 – 1.80
52-week range
1.40 – 12.25
52-week change
-75.00%
Beta
—
Volume
556.72K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
116.61M
Forward Pe
-1.09
Eps
-2.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
12.25
Week52 Low
1.40
Avg Volume
1.12M
Shares Outstanding
67.02M
Ma50
1.79
Ma200
3.75
Earnings Date
Sep 8, 2026
Pct From52w High
-85.80%
Pct From52w Low
24.29%

Related